Pediatrix Medical Group, Inc.
For the period ended Mar 26, 2025. Filed Mar 28, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Mar 26, 2025 · Filed Mar 28, 2025
Contents
Elements of Pay
Our pay philosophy was supported by the following pay elements in our executive compensation program for 2024:
| Element | Form | Description |
|---|---|---|
| Base Salary | Cash (Fixed) | Provides a competitive level of pay that reflects the executive’s experience, role and responsibilities and performance. |
| Annual Bonus | Cash (Variable) | Based 80% on annual Adjusted Income from Operations performance and 20% on certain non-financial metrics. |
| Long-Term Incentives | Equity (Variable) | Comprised of 50% restricted stock that vests over three years (back end weighted) and 50% performance shares tied to the achievement of annual Adjusted EBITDA targets and a three-year ROIC modifier. Any performance shares earned will vest at the end of the full three-year period. |
In 2023, we adjusted the performance share aspect of our long-term incentives by issuing performance-based equity awards with three one-year performance periods. New performance goals will be set each year and awards for which the performance goals have been met will vest at the end of the full three-year period. In addition, the performance shares are also subject to a three-year ROIC modifier that may adjust the final payout up or down by as much as 20%.
| Pediatrix Medical Group, Inc. | 36 | 2025 Proxy Statement |
|---|
Executive Compensation: Compensation Discussion and Analysis (“CD&A”)
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.